Related Experiment Video
Updated: Jan 7, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes
Rafael Gonzalez-Manzanares1,2,3, María Anguita-Gámez4, Javier Muñiz3,5
1Department of Cardiology, Reina Sofía University Hospital, Córdoba, Spain.
Insights
Heart failure (HF) and type 2 diabetes (T2D) affect men and women similarly in prevalence and prognosis. However, women with T2D present more often with HF with preserved ejection fraction (HFpEF) and receive less guideline-directed therapy.
Area of Science:
- Cardiology
- Endocrinology
- Sex-based Medicine
Background:
- Type 2 diabetes (T2D) and heart failure (HF) frequently coexist, leading to adverse outcomes.
- Exploring sex-related differences in HF presentation and outcomes within a T2D population is crucial.
Purpose of the Study:
- To investigate sex-based disparities in the characteristics, treatment, and 3-year clinical outcomes of heart failure among patients with type 2 diabetes.
Main Methods:
- A prospective cohort study of 1,249 type 2 diabetes outpatients across 30 Spanish centers.
- Heart failure classified by left ventricular ejection fraction (LVEF): HFrEF (<40%), HFmrEF (40-49%), and HFpEF (≥50%).
- Assessment of sex-related differences in HF presentation, treatment patterns, and 3-year clinical outcomes.
Main Results:
- HF prevalence was similar between sexes at baseline and 3 years.
- Women predominantly presented with HFpEF, while men showed a higher prevalence of HFrEF (p < 0.001).
- Women with HFrEF received fewer angiotensin receptor-neprilysin inhibitors, and women with HFpEF were more often treated with diuretics compared to men.
Conclusions:
- Despite similar HF prevalence and prognosis in T2D patients, significant sex-based differences exist in HF presentation, favoring HFpEF in women.
- Women with HF were less likely to receive optimal guideline-directed medical therapies, highlighting a need for sex-specific management strategies.
Background:
Heart failure (HF) and type 2 diabetes (T2D) frequently coexist and contribute to adverse outcomes. We aimed to explore sex-related differences in HF presentation and outcomes in a nationwide cohort of T2D outpatients.
Materials And Methods:
We analyzed a prospective cohort of 1,249 T2D outpatients recruited from cardiology and endocrinology clinics across 30 Spanish centers. HF was classified according to left ventricular ejection fraction (LVEF) into reduced (HFrEF; LVEF <40%), mid-range (HFmrEF; LVEF 40-49%), and preserved ejection fraction (HFpEF; LVEF ≥50%). Sex-related differences in HF characteristics, treatment, and 3-year clinical outcomes were assessed.
Results:
HF prevalence did not differ significantly between women and men (initial visit: 37.2% versus 40.4%, p = 0.285; 3-year visit: 45.9% versus 51.7%, p = 0.294). However, HFpEF predominated among women and HFrEF among men (p < 0.001). HF was associated with increased mortality (odds ratio 4.26; 95% confidence interval, 2.65-7.04; p < 0.001), with no interaction by sex (p for interaction = 0.326). Women with HFrEF were less likely to receive angiotensin receptor-neprilysin inhibitors (44.2% versus 62.9%, p = 0.035). Among HFpEF patients, women were more frequently treated with diuretics (82.4% vs 66.5%, p = 0.009).
Conclusion:
Despite similar prevalence and prognosis, women were more likely to present with HFpEF and were less likely to receive optimal guideline-directed therapies, underscoring sex-based differences in both the presentation and management of HF.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
Heart Failure Drugs: Diuretics